In a nutshell This is the first study to look at the development of both secondary cancers and cardiovascular disease (CVD) as late side effects of Hodgkin lymphoma (HL) treatment. The study concluded that there was an increased risk of developing both a secondary cancer and CVD in patients treated before 2000. Some background...Read More
Treatment(s) now being considered-Radiation Posts on Medivizor
In a nutshell This study aimed to examine the risk of developing a secondary cancer after breast conserving therapy for early stage breast cancer patients. This study found that patients who have been treated for early stage breast cancer do not have a significantly higher risk of secondary cancers. Some background Women with early stage breast...Read More
What are the long-term outcomes for HL patients who experience treatment failure after an autologous stem cell transplant?
In a nutshell This study analyzed the survival outcomes of Hodgkin’s lymphoma (HL) patients who experience treatment failure after high-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (autoSCT). This study concluded that a second stem cell transplant with or without brentuximab vedotin (Adcetris) may lead to better...Read More
In a nutshell The authors aimed to determine the benefit of brachytherapy in men with prostate cancer. The authors recommended brachytherapy treatments in men with low-, intermediate- and high-risk prostate cancer alone or in combination with other treatments. Some background Brachytherapy is a form of radiation therapy. It involves implanting a seed...Read More
In a nutshell This study looked at the long term outcomes for patients with Hodgkin lymphoma who were treated with radiation therapy. The study concluded that patients treated with radiation therapy had better outcomes compared to patients not treated with radiation therapy. Some background Patients with Hodgkin lymphoma (HL) generally have good...Read More
In a nutshell This study examined the incidence of pleural effusion in lung cancer patients after treatment with thoracic radiation therapy and identified risk factors associated with it. They concluded that patients treated with 5 Gy of radiation to over 41.5% of the lung were at the greatest risk of developing pleural effusion after treatment. Some...Read More
In a nutshell This review explored the risk of developing a secondary cancer after being treated for Hodgkin lymphoma with chemotherapy and/or radiotherapy. The review concluded that intensified chemotherapy and radiotherapy are more effective but are associated with a greater risk of developing a secondary cancer. Some background Hodgkin...Read More
In a nutshell This study examined whether radiotherapy treatment before surgery could improve disease-free survival, especially for patients with estrogen-receptor positive (ER+) breast cancer (dependent on the hormone estrogen for growth). This study concluded that radiotherapy before surgery improved disease-free survival. Some background For...Read More
Is chemoradiation with local removal, better than total surgical removal to treat stage II rectal cancer?
In a nutshell This study looked survival rates of stage II rectal cancer patients who underwent different treatments. It compared radical surgery versus local excision with added-on chemoradiation. The article concluded that overall survival was not different between the treatments. Some background Radical surgery (RS – complete...Read More
In a nutshell The authors aimed to determine patients who would benefit from early salvage radiation therapy (SRT) after prostate surgery. The authors concluded that early SRT is only beneficial for selected patients who experience cancer recurrence after prostate surgery. Some background Prostate surgery is a common prostate cancer...Read More
In a nutshell This study examined the effect of pre-surgical chemotherapy without radiotherapy in stage II/III rectal cancer. The study showed that combined targeted chemotherapy was effective in these patients. Some background Rectal cancer is a cancer of the end part of the digestive system. In stage II and III, the cancer has begun to...Read More
In a nutshell The authors aimed to determine the effect of tumor-directed stereotactic body radiotherapy in prostate cancer patients with oligometastases. The authors concluded that tumor-directed stereotactic body radiotherapy was a useful treatment for both oligorecurrent and oligoprogressive castration-resistant prostate cancer. Some...Read More